The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
RhoH modulates pre-TCR and TCR signalling by regulating LCK
Abstract
Pre-T-cell receptor (pre-TCR) and TCR signals govern the development of T-lymphocytes. RhoH, a hematopoietic-specific and GTPase-deficient member of the RhoGTPase family, is required in the development of T-lymphocytes. Here we found that RhoH binds and modulates LCK, the non-receptor tyrosine kinase crucial in initiating pre-TCR and TCR signallings. In both pre-TCR and TCR signalling transduction, LCK is phosphorylated by CSK to maintain the inactive state of LCK at rest. Upon being activated, CSK phosphorylation is removed and LCK autophosphorylation leads to LCK activation and further phosphorylates ZAP70 to initiate further downstream signalling. At rest, LCK may be recruited to the plasma membrane by RhoH, which also binds CSK, resulting in LCK inactivation. Additionally, the presence of RhoH enhances the inactivation phosphorylation of LCK by CSK. RhoH was found to bind preferentially inactive LCK, indicating that, upon ligand-mediated TCR activation, LCK is dephosphorylated resulting in LCK autoactivation and its release from RhoH. Thus RhoH is a critical part of the microenvironment for maintaining the inactive state of LCK. Furthermore, we found that the reduction of RhoH levels results in LCK autoactivation and constitutive activation of the TCR pathway. Our findings indicate that RhoH is a key adapter protein that maintains LCK in the inactive state, contributing to the regulation of both pre-TCR and TCR signalling during T-cell development. The data also supports…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RhoH serves as adaptor molecule in T cell receptor signaling and RhoH expression correlates with the unfavorable prognostic marker ZAP70 in human chronic lymphocytic leukemia.”
From A Unique Carboxyl-terminal Insert Domain in the Hematopoietic-specific, GTPase-deficient Rho GTPase RhoH Regulates Post-translational Processing (2013) · cites this paper as [11]
In the citing paper
“RhoH is required for proper localization and activation of ZAP70 and LCK in TCR signaling (8 -11).”
From A Unique Carboxyl-terminal Insert Domain in the Hematopoietic-specific, GTPase-deficient Rho GTPase RhoH Regulates Post-translational Processing (2013) · cites this paper as [11]
In the citing paper
“In addition it has been demonstrated that RhoH interacts with inactive, c-src tyrosine kinase (CSK) phosphorylated Lck that is also involved in pre-TCR and TCR signaling73.”
From Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders (2013) · cites this paper as [73]
In the citing paper
“Downregulation of Rac1 activity by RhoH might be due to its role in enhancing the inactivation phosphorylation of Lck by C-terminal Src kinase (CSK) [37].”
From The Role of RhoH in TCR Signalling and Its Involvement in Diseases (2021) · cites this paper as [37]
In the citing paper
“However, in response to ligand-mediated TCR activation, Lck is recruited to the membrane by RhoH and dephosphorylated by CD45, resulting in Lck auto-activation and its release from RhoH [37].”
From The Role of RhoH in TCR Signalling and Its Involvement in Diseases (2021) · cites this paper as [37]
Citations
Cites
Li, X., Bu, X., Lu, B., Avraham, H., Flavell, R. A., & Lim, B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1158-1171.2002 · Cited by 153
Self-citationLysosomal degradation of RhoH protein upon antigen receptor activation in T but not B cells
Schmidt‐Mende, J., Geering, B., Yousefi, S., & Simon, H. (2010) · European Journal of Immunology · doi:10.1002/eji.200939556 · Cited by 20
Cited by
Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections
Crequer, A., Troeger, A., Patin, E., Ma, C. S., Picard, C., Pedergnana, V., Fieschi, C., Lim, A., Abhyankar, A., Gineau, L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62949 · Cited by 159
Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders
Troeger, A., & Williams, D. A. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.07.002 · Cited by 73
The Role of RhoH in TCR Signalling and Its Involvement in Diseases
Ahmad Mokhtar, A. M., Hashim, I. F., Mohd Zaini Makhtar, M., Salikin, N. H., & Amin-Nordin, S. (2021) · Cells · doi:10.3390/cells10040950 · Cited by 25
RhoH is a negative regulator of eosinophilopoiesis
Stoeckle, C., Geering, B., Yousefi, S., Rožman, S., Andina, N., Benarafa, C., & Simon, H.-U. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.73 · Cited by 24
Troeger, A., Chae, H.-D., Senturk, M., Wood, J., & Williams, D. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.505727 · Cited by 15
Overexpression of RhoH Permits to Bypass the Pre-TCR Checkpoint
Tamehiro, N., Oda, H., Shirai, M., & Suzuki, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131047 · Cited by 14
Galiègue‐Zouitina, S., Fu, Q., Carton‐Latreche, C., Poret, N., Cheok, M., Leprêtre, F., Figeac, M., Quesnel, B., El Bouazzati, H., & Shelley, C. S. (2021) · eJHaem · doi:10.1002/jha2.128 · Cited by 7
Zhou, J., Qian, M., Jiang, N., Wu, J., Feng, X., Yu, M., Min, Q., Xu, H., Yang, Y., Yang, Q., et al. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-024-01735-4 · Cited by 4
Metadata
- Authors
- Wang, H., Zeng, X., Fan, Z., & Lim, B.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 23
- Issue
- 1
- Pages
- 249-258
- ISSN
- 0898-6568
- Cited by
- 39
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review